Ocrevus 300 MG/1 ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9NB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,457
Award facts
- Contract value 100% obligated
- $38,456.55 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,456.55 to AmerisourceBergen Drug Corp for the supply of Ocrevus (ocrelizumab) 300 mg/1 mL, a specialty pharmaceutical product used primarily in the treatment of multiple sclerosis. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of January 5, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. Through this contract structure, AmerisourceBergen provides critical pharmaceutical commodities to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FW9NB?
SPE2DR26FW9NB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FW9NB worth?
The government has obligated $38,457 on SPE2DR26FW9NB.
Is contract SPE2DR26FW9NB an order under another contract?
Yes. SPE2DR26FW9NB is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9NB competed?
The extent of competition for SPE2DR26FW9NB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award